Filing Flows

Filing Flows › Niagen Bioscience (NAGE) › Next earnings date

Niagen Bioscience (NAGE) earnings: beat the estimate

Niagen Bioscience (NAGE) reported on Nov 4, 2026 and beat the EPS estimate: −$0.01 against −$0.03 (+52.7%). Revenue was $27.2M for Q3 2026, -20% year over year. It beat the EPS estimate in 80% of the quarters on record.

Last result+52.7% vs estimate
Beat rate80%

The last report

Niagen Bioscience reported revenue of $27.2M for the third quarter 2026 (-20% Y/Y), net loss $1.2M: Consumer Products segment $23.3M, Ingredients segment $3.8M. How it makes money → · Every quarter →

Niagen Bioscience: EPS against the estimate, last 5 reportsNiagen Bioscience: EPS against the estimate, last 5 reportsEstimateReported$0.01$0.05Nov 25$0.02$0.03Mar 26$0.06$0.02May 26−$0.01$0.01Aug 26−$0.03−$0.01Nov 26
Latest (Nov 26): Estimate −$0.03, Reported −$0.01.

Niagen Bioscience's latest quarter

Niagen Bioscience, Q3 2026: revenue $27.2M (-20% year over year), operating margin -5.8%, net loss $1.2M, operating cash flow $2.6M. The chart follows the revenue to costs, profit and cash.

Questions

Did Niagen Bioscience beat earnings?

Niagen Bioscience (NAGE) reported on Nov 4, 2026 and beat the EPS estimate: −$0.01 against −$0.03 (+52.7%).

When does NAGE report earnings?

The next date is not set yet.

Does Niagen Bioscience usually beat earnings?

It beat the consensus EPS estimate in 80% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.